Goldman Sachs 46th Annual Global Healthcare Conference

06/11/2025 | 11:00am PDT / 2:00pm EDT

Webcast Link

Events & Presentations

  • Goldman Sachs 46th Annual Global Healthcare Conference

    06/11/2025 | 11:00am PDT / 2:00pm EDT

    Watch the webcast

  • The BofA Securities 2025 Health Care Conference

    05/14/2025 | 3:00pm PDT / 6:00pm EDT

    Watch the webcast

  • Myriad Genetics First Quarter 2025 Financial Earnings

    05/06/2025 | 1:30pm PDT / 4:30pm EDT

    Watch the webcast View the document
View all events

Financial Reports and Filings

Date Filing Title Downloads
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/05/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
06/05/2025 S-8 Securities offered to employees pursuant to employee benefit plans RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen Thumbnail

Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen

Jun 03, 2025 | Products

Read more
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types Thumbnail

Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types

Jun 02, 2025 | Products

Read more
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting Thumbnail

Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting

May 27, 2025 | Products | Pipeline

Read more
View all news releases

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report